[
    [
        {
            "time": "2023-10-01",
            "original_text": "Why Neurocrine Biosciences Stock Is Jumping Today",
            "features": {
                "keywords": [
                    "Neurocrine",
                    "Biosciences",
                    "Jumping"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Why Neurocrine Biosciences Stock Is Jumping Today",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "Merck Shares Rise on Strong Sales Growth",
            "features": {
                "keywords": [
                    "Merck",
                    "Shares",
                    "Rise",
                    "Strong",
                    "Sales",
                    "Growth"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Merck Shares Rise on Strong Sales Growth",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "Cramer Weighs In On AbbVie, Six Flags And More",
            "features": {
                "keywords": [
                    "Cramer",
                    "AbbVie",
                    "Six",
                    "Flags"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "entertainment"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Cramer Weighs In On AbbVie, Six Flags And More",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "Bayer (BAYRY) Q2 Earnings Match Estimates, Sales Up Y/Y",
            "features": {
                "keywords": [
                    "Bayer",
                    "Q2",
                    "Earnings",
                    "Match",
                    "Estimates",
                    "Sales",
                    "Up",
                    "Y/Y"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Bayer (BAYRY) Q2 Earnings Match Estimates, Sales Up Y/Y",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "Dr. Reddy's (RDY) Q1 Earnings and Revenues Increase Y/Y",
            "features": {
                "keywords": [
                    "Dr.",
                    "Reddy's",
                    "Q1",
                    "Earnings",
                    "Revenues",
                    "Increase",
                    "Y/Y"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Dr. Reddy's (RDY) Q1 Earnings and Revenues Increase Y/Y",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "The 5 Worst S&P 500 Stocks Are Costing You $22.3 Billion; Here's Why",
            "features": {
                "keywords": [
                    "Worst",
                    "S&P",
                    "500",
                    "Stocks",
                    "Costing",
                    "$22.3",
                    "Billion"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "general market"
                ],
                "causal_factor": "false",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "The 5 Worst S&P 500 Stocks Are Costing You $22.3 Billion; Here's Why",
                "Correlation": 5,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 10,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "Neurocrine Biosciences Posts Sizzling Sales Growth in Q2",
            "features": {
                "keywords": [
                    "Neurocrine",
                    "Biosciences",
                    "Sizzling",
                    "Sales",
                    "Growth",
                    "Q2"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Neurocrine Biosciences Posts Sizzling Sales Growth in Q2",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]